文献速递冠心病外科瓣膜外科主动脉外科

del Nido停搏液在成人心脏手术中的临床影响:一项前瞻性随机试验

Clinical impact of del Nido cardioplegia in adult cardiac surgery: A prospective randomized trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-02-08

该研究将474例接受冠状动脉旁路移植术、心脏瓣膜手术、胸主动脉手术或联合手术的成人患者随机分为del Nido停搏液组(n=234)和冷血停搏液组(n=240),比较心肌保护效果。结果显示两组在术后正性肌力支持需求和严重心血管事件方面无显著差异,但del Nido组恢复自主窦性心律的比例更高、除颤尝试次数更少、术后肌钙蛋白峰值出现更早,且血糖控制和术后卒中发生率更优。

要点

  • del Nido停搏液可安全用于成人心脏手术,与传统停搏液相比结局相当
  • del Nido组恢复自主窦性心律比例更高(P< .001),除颤尝试次数更少(P< .001)
  • del Nido组术后卒中发生率更低(2.6% vs 6.7%;P= .035),但需进一步研究

核心结论

  • del Nido停搏液可安全使用,与传统停搏液相比结局相当。
  • 在血糖控制、再灌注心律失常和舒适的再次给药间期方面具有额外优势,使其成为成人心脏手术中心肌保护的有趣替代选择。
  • 术后卒中的显著减少需要进一步研究以阐明本研究结果。

研究设计与样本

  • 前瞻性随机试验,共纳入474例接受冠状动脉旁路移植术、心脏瓣膜手术、胸主动脉手术或联合手术的成人患者。
  • 患者知情同意后随机分为del Nido停搏液组(n=234)或冷血停搏液组(n=240)。
  • 主要终点为重症监护室停留前48小时内的正性肌力支持需求、严重心血管事件和肌钙蛋白趋势。
  • 次要终点包括再灌注心律失常、主动脉阻断时间和体外循环时间及其他临床围术期变量。

主要发现

  • 术后正性肌力支持需求或严重心血管事件发生率方面未发现统计学显著差异。
  • del Nido组恢复自主窦性心律的比例更高(P< .001),除颤尝试次数更少(P< .001),术后肌钙蛋白峰值出现更早。
  • del Nido组峰值血糖水平和静脉胰岛素需求量显著更低。
  • 主动脉阻断时间或体外循环时间方面未发现显著差异。
  • del Nido组术后卒中发生率更低(2.6% vs 6.7%;P= .035)。

临床怎么用

  • 作者认为del Nido停搏液可安全使用,与传统停搏液相比结局相当,并在血糖控制、再灌注心律失常和再次给药间期方面具有额外优势,是成人心脏手术中心肌保护的有趣替代选择。
  • 作者指出术后卒中的显著减少需要进一步研究以阐明本研究结果。

局限性

  • 术后卒中的显著减少需要进一步研究以阐明本研究结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study objective was to assess the benefits of del Nido cardioplegia compared with cold blood cardioplegia solution in terms of myocardial protection during adult cardiac surgery. METHODS: A total of 474 adult patients undergoing coronary artery bypass grafting, heart valve surgery, thoracic aortic surgery, or combined procedures were randomized to the del Nido cardioplegia group (n = 234) or the cold blood cardioplegia solution group (n = 240) after provided informed consent. The primary end points assessed inotropic support requirements, severe cardiovascular events, and troponin trend within the first 48 hours of intensive care unit stay. Reperfusion arrhythmias, aortic crossclamp and cardiopulmonary bypass times, and other clinical perioperative variables were considered as secondary end points. RESULTS: No statistically significant differences were found regarding postoperative inotropic support requirements or the incidence of severe cardiovascular events. The del Nido cardioplegia group showed a higher return to spontaneous sinus rhythm (P< .001), a lower number of defibrillation attempts (P< .001), and an earlier peak troponin value in the postoperative period. Peak blood glucose levels and intravenous insulin requirements were significantly lower in the del Nido cardioplegia group. We found no significant differences regarding aortic crossclamp or cardiopulmonary bypass time. We did observe a lower incidence of postoperative stroke in the del Nido cardioplegia group (2.6% vs 6.7%; P= .035). CONCLUSIONS: del Nido cardioplegia can be used safely and with comparable outcomes compared with traditional cardioplegia solutions. Additional advantages over glycemic control, reperfusion arrhythmias, and its comfortable redosing interval make del Nido an interesting alternative for myocardial protection in adult cardiac surgery. A significant decrease in postoperative stroke will require further research to shed light on the results of this study. VIDEO ABSTRACT.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Garcia-Suarez J, Garcia-Fernandez J, Martinez Lopez D, et al. Clinical impact of del Nido cardioplegia in adult cardiac surgery: A prospective randomized trial. J Thorac Cardiovasc Surg. 2022. PMID: 35279289. doi:10.1016/j.jtcvs.2022.01.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。